KR880003605A - 헤파린-함유 유착방지 장벽 및 사용방법 - Google Patents

헤파린-함유 유착방지 장벽 및 사용방법 Download PDF

Info

Publication number
KR880003605A
KR880003605A KR870010809A KR870010809A KR880003605A KR 880003605 A KR880003605 A KR 880003605A KR 870010809 A KR870010809 A KR 870010809A KR 870010809 A KR870010809 A KR 870010809A KR 880003605 A KR880003605 A KR 880003605A
Authority
KR
South Korea
Prior art keywords
heparin
fabric
adhesion
absorbed
organs
Prior art date
Application number
KR870010809A
Other languages
English (en)
Other versions
KR950013460B1 (ko
Inventor
린스키 캐리
커닝햄 티모씨
파인스 엘리
Original Assignee
웨인 알. 에버하트
죤슨 앤드 죤슨 프로덕츠, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 웨인 알. 에버하트, 죤슨 앤드 죤슨 프로덕츠, 인코포레이티드 filed Critical 웨인 알. 에버하트
Publication of KR880003605A publication Critical patent/KR880003605A/ko
Application granted granted Critical
Publication of KR950013460B1 publication Critical patent/KR950013460B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/424—Anti-adhesion agents

Abstract

내용 없음

Description

헤파린-함유 유착방지 장벽 및 사용방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 신체기관을 감쌀 수 있고 이에 적합하며 부착성이 있고, 신체내에서 30일 이내에 거의 흡수될 수 있으며, 무독성의 유착방지 유효량 및 역가로 존재하는 헤파린을 갖는 산화된 재생성 셀룰로오즈 직물을 함유하는 개선된 유착방지 장벽 직물.
  2. 제1항에 있어서, 직물에 흡수된 헤파린을 외과수술 동안 신체 기관상에 실용시 액체 형태로 직물에 적용시키는 개선된 유착방지 장벽 직물.
  3. 제1항에 있어서, 헤파린을 언급한 직물상에 흡수시킨 후, 건조시킨, 개선된 유착방지 장벽 직물.
  4. 제1항에 있어서, 헤파린을 직물상에 흡수시키고 헤파힌 함유 직물을 건조시킨 후 무균 상태로 밀봉한 개선된 유착방지 장벽 직물.
  5. 제1항에 있어서, 사용된 헤파린의 양이 직물을 포화시키기에 충분하면서 헤파린이 방울져 떨어지지 않을 정도인 개선된 유착방지 장벽 직물.
  6. 제1항에 있어서, 사용된 헤파린이 100 내지 2000 미국 약전(usp)헤파린 단위의 역가를 갖는 주사용 헤파린 나트륨 형태인 개선된 유착방지 장벽 직물.
  7. 제1항에 있어서, 산화된 재생성 셀룰로오즈 직물이 편직물인 개선된 유착방지 장벽 직물.
  8. 외과수술 부위와 인접 조직간에 제1 내지 제 7항중 어느 한 항의 헤파린 함유 산화된 재생성 셀룰로오즈 유착방지 장벽 직물을 물리적으로 장벽으로서 장치함을 특징으로 하여, 외과적 유착을 방지하는 방법.
  9. 신체기관을 감쌀 수 있고, 이에 적합하며 부착성이 있고 신체내에서 30일 이내에 거의 흡수될 수 있는, 직물상에 흡수된 헤파린을 함유하는 산화된 재생성 셀룰로즈 직물을 신체 내부 기관의 외면에 적용시킴을 특징으로 하여, 외과수술 중 외과적 유착을 방지하기 위해 헤파린을 신체 내부 기관에 국소적으로 투여하는 방법.
  10. 제9항에 있어서, 직물을 언급한 체내 기관에 적용시킨 후, 헤파린을 산화된 재생성 셀룰로즈 직물상에 흡수시키는 방법.
  11. 제9항에 있어서, 직물을 신체 기관에 적용시키기 전에 헤파린을 산화된 재생성 셀룰로즈 직물상에 흡수시키는 방법.
  12. 제9,10 또는 11항에 있어서, 산화된 재생성 셀룰로오즈 직물상의 헤파린 양이 직물상에 또는 직물내에 모두 잔존하여 과량의 헤파린이 다른 기관 또는 체강내로 유입되지 않고 헤파린 부재시 일어나는 정도 이상의 유착을 방지하기에 충분하나 직물을 포화시키는 양 이하이며 헤파린의 역가가 100 내지 2000usp헤파린 단위인 방법.
  13. 외과수술에 사용하기에 안전하며 신체기관을 감쌀 수 있고, 이에 적합하며 부착성이 있고, 신체 내에서 30일 이내에 거의 흡수될 수 있으며, 매트릭스 상에 무독성의 유착 방지 유효량 및 역가로 존재하는 헤파린을 함유하는 매트릭스로 구성된 개선된 유착방지용 장벽 물질.
  14. 외과수술 부위와 인접 조직간에 제13항의 헤파린 함유 유착 방지용 장벽 물질을 물리적 장벽으로서 장치함을 특징으로 하는 외과적 유착을 방지하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870010809A 1986-09-29 1987-09-29 헤파린-함유 유착 방지용 차단물 KR950013460B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/912,450 US4840626A (en) 1986-09-29 1986-09-29 Heparin-containing adhesion prevention barrier and process
US912450 1986-09-29

Publications (2)

Publication Number Publication Date
KR880003605A true KR880003605A (ko) 1988-05-28
KR950013460B1 KR950013460B1 (ko) 1995-11-08

Family

ID=25431943

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870010809A KR950013460B1 (ko) 1986-09-29 1987-09-29 헤파린-함유 유착 방지용 차단물

Country Status (17)

Country Link
US (1) US4840626A (ko)
EP (1) EP0262890B1 (ko)
JP (1) JP2563110B2 (ko)
KR (1) KR950013460B1 (ko)
AT (1) ATE98132T1 (ko)
AU (1) AU602726B2 (ko)
CA (1) CA1300022C (ko)
DE (1) DE3788404T2 (ko)
DK (1) DK510687A (ko)
ES (1) ES2047493T3 (ko)
GR (1) GR871484B (ko)
IE (1) IE63282B1 (ko)
MX (1) MX165863B (ko)
MY (1) MY100808A (ko)
NZ (1) NZ221806A (ko)
PH (1) PH24128A (ko)
ZA (1) ZA877284B (ko)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
US5140016A (en) * 1988-05-31 1992-08-18 University Of Florida Method and composition for preventing surgical adhesions using a dilute solution of polymer
US6010692A (en) * 1988-05-31 2000-01-04 University Of Florida Research Foundation, Inc. Method and composition for preventing surgical adhesions and tissue damage
ZA899326B (en) * 1988-12-07 1991-08-28 Johnson & Johnson Patient Care Low molecular weight heparin,heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
CA2033046C (en) * 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
US5282829A (en) * 1991-08-15 1994-02-01 United States Surgical Corporation Hollow body implants
DK0601055T3 (da) * 1991-08-16 2000-10-02 Joseph C Salamone Medikamentovertrukket brydende okulært forkammerimplantat
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US7117868B1 (en) 1992-05-29 2006-10-10 3M Innovative Properties Company Fibrous filtration face mask having a new unidirectional fluid valve
US5263629A (en) * 1992-06-29 1993-11-23 Ethicon, Inc. Method and apparatus for achieving hemostasis along a staple line
US5279539A (en) * 1992-08-17 1994-01-18 Ethicon, Inc. Drawstring surgical pouch and method of use for preventing ovarian adhesions
CA2114290C (en) * 1993-01-27 2006-01-10 Nagabushanam Totakura Post-surgical anti-adhesion device
US5542594A (en) * 1993-10-06 1996-08-06 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5505952A (en) * 1994-04-19 1996-04-09 United States Surgical Corporation Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
US5601579A (en) * 1994-12-29 1997-02-11 Medex, Inc. Method for the treatment of bowel adhesions
AU697045B2 (en) * 1995-01-16 1998-09-24 Baxter International Inc. Self-supporting sheet-like material of cross-linked fibrin for preventing post- operative adhesions
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
US6461640B1 (en) 1995-12-08 2002-10-08 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
EP0917444A1 (en) 1996-07-12 1999-05-26 Baxter Travenol Laboratories, Inc. A fibrin delivery device and method for forming fibrin on a surface
FR2778081B1 (fr) 1998-04-29 2000-08-25 Fabrice Thevenet Implants de renfort pour sutures tissulaires
BE1012536A3 (fr) 1998-11-04 2000-12-05 Baxter Int Element muni d'une couche de fibrine sa preparation et son utilisation.
US6548569B1 (en) 1999-03-25 2003-04-15 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6325810B1 (en) 1999-06-30 2001-12-04 Ethicon, Inc. Foam buttress for stapling apparatus
DE60018571T8 (de) * 1999-07-28 2006-04-27 Davol Inc. Hernienprothese
US6702732B1 (en) 1999-12-22 2004-03-09 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6273897B1 (en) 2000-02-29 2001-08-14 Ethicon, Inc. Surgical bettress and surgical stapling apparatus
CA2402504A1 (en) * 2000-03-10 2001-09-20 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
US6425856B1 (en) * 2000-05-10 2002-07-30 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US7404819B1 (en) 2000-09-14 2008-07-29 C.R. Bard, Inc. Implantable prosthesis
US6685956B2 (en) 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
DE60227676D1 (de) 2001-09-07 2008-08-28 Mardil Inc Verfahren und gerät für die externe herzstabilisierung
JP2005501652A (ja) * 2001-09-10 2005-01-20 パラコー メディカル インコーポレイテッド 心不全治療用装置
CA2460307A1 (en) * 2001-10-31 2003-05-08 Paracor Medical, Inc. Heart failure treatment device
US7022063B2 (en) 2002-01-07 2006-04-04 Paracor Medical, Inc. Cardiac harness
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US7174896B1 (en) 2002-01-07 2007-02-13 Paracor Medical, Inc. Method and apparatus for supporting a heart
US7252837B2 (en) * 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040101548A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
US7279177B2 (en) * 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
US20040037866A1 (en) * 2002-08-20 2004-02-26 Semertzides John N. Composition and method for the treatment and prevention of adhesions
WO2004021927A2 (en) 2002-09-05 2004-03-18 Paracor Medical, Inc. Cardiac harness
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US7736299B2 (en) 2002-11-15 2010-06-15 Paracor Medical, Inc. Introducer for a cardiac harness delivery
EP1560541A2 (en) 2002-11-15 2005-08-10 Paracor Medical, Inc. Cardiac harness delivery device
US7229405B2 (en) 2002-11-15 2007-06-12 Paracor Medical, Inc. Cardiac harness delivery device and method of use
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040249242A1 (en) * 2003-03-28 2004-12-09 Lilip Lau Multi-panel cardiac harness
US20040241212A1 (en) * 2003-05-30 2004-12-02 Pendharkar Sanyog Manohar Biodegradable hemostatic wound dressings
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
CA2530429A1 (en) * 2003-07-10 2005-01-27 Paracor Medical, Inc. Self-anchoring cardiac harness
US7158839B2 (en) * 2003-11-07 2007-01-02 Paracor Medical, Inc. Cardiac harness for treating heart disease
US20050171589A1 (en) * 2003-11-07 2005-08-04 Lilip Lau Cardiac harness and method of delivery by minimally invasive access
US20050137673A1 (en) * 2003-11-07 2005-06-23 Lilip Lau Cardiac harness having electrodes and epicardial leads
US7155295B2 (en) 2003-11-07 2006-12-26 Paracor Medical, Inc. Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
US20050129733A1 (en) * 2003-12-09 2005-06-16 Milbocker Michael T. Surgical adhesive and uses therefore
JP2007518490A (ja) * 2004-01-12 2007-07-12 パラコー メディカル インコーポレイテッド 相互結合するストランドを有する心臓ハーネス
US8298290B2 (en) * 2004-09-20 2012-10-30 Davol, Inc. Implantable prosthesis for soft tissue repair
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US20060257457A1 (en) * 2004-10-20 2006-11-16 Gorman Anne J Method for making a reinforced absorbable multilayered hemostatic wound dressing
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
EP2345430B1 (en) * 2004-10-20 2015-11-25 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
CA2584679C (en) * 2004-10-20 2015-01-27 Ethicon, Inc. Hemostat
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) * 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US7587247B2 (en) * 2005-08-01 2009-09-08 Paracor Medical, Inc. Cardiac harness having an optimal impedance range
US20070208217A1 (en) * 2006-03-03 2007-09-06 Acorn Cardiovascular, Inc. Self-adjusting attachment structure for a cardiac support device
US20070270882A1 (en) * 2006-05-19 2007-11-22 Acorn Cardiovascular, Inc. Pericardium management method for intra-pericardial surgical procedures
US20080097146A1 (en) * 2006-06-29 2008-04-24 Acorn Cardiovascular, Inc. Cardiac support device with low friction delivery structures
US7651462B2 (en) 2006-07-17 2010-01-26 Acorn Cardiovascular, Inc. Cardiac support device delivery tool with release mechanism
US7641608B1 (en) 2006-09-26 2010-01-05 Acorn Cardiovascular, Inc. Sectional cardiac support device and method of delivery
US9289279B2 (en) 2006-10-06 2016-03-22 Promethean Surgical Devices, Llc Apparatus and method for limiting surgical adhesions
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer
US8299316B2 (en) * 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
US20110165578A1 (en) * 2008-09-09 2011-07-07 Daniela Verthelyi Methods for detecting and quantifying oversulfated glycosaminoglycans
WO2010039249A1 (en) 2008-10-03 2010-04-08 C.R. Bard, Inc. Implantable prosthesis
US20110152924A1 (en) * 2009-12-22 2011-06-23 Michel Gensini Oxidized regenerated cellulose adhesive tape
US9192385B2 (en) 2010-10-12 2015-11-24 Evan Richard Geller Device and method to facilitate safe, adhesion-free surgical closures
US20130084324A1 (en) 2011-09-30 2013-04-04 Michel Gensini Adhesion prevention fabric
US9796769B2 (en) 2012-09-28 2017-10-24 Ension Inc. Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members
US10744039B2 (en) 2012-09-28 2020-08-18 Ension Inc. Methods of making bioactive collagen wound care dressings
CA2898620C (en) 2012-10-12 2022-10-04 Mardil, Inc. Cardiac treatment system and method
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US9655621B2 (en) * 2013-03-15 2017-05-23 Covidien Lp Surgical instrument for dispensing tacks and solution
USD717954S1 (en) 2013-10-14 2014-11-18 Mardil, Inc. Heart treatment device
KR101878774B1 (ko) * 2015-04-15 2018-07-17 주식회사 삼양바이오팜 다기능성 지혈제 및 그 제조 방법
JP2019517892A (ja) 2016-06-15 2019-06-27 チュビタック （ターキー ビリムセル ヴィ テクノロジク アラスティルマ クルム）Ｔｕｂｉｔａｋ （Ｔｕｒｋｉｙｅ Ｂｉｌｉｍｓｅｌ Ｖｅ Ｔｅｋｎｏｌｏｊｉｋ Ａｒａｓｔｉｒｍａ Ｋｕｒｕｍｕ） 多機能ヘルニアパッチ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3122479A (en) * 1957-11-14 1964-02-25 David F Smith Hemostatic surgical dressings
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3902497A (en) * 1974-03-25 1975-09-02 American Cyanamid Co Body absorbable sponge and method of making
JPS5941647B2 (ja) * 1981-03-31 1984-10-08 工業技術院長 抗血液凝固性再生セルロ−スの製造法
JPS5941656B2 (ja) * 1981-03-31 1984-10-08 工業技術院長 再生セルロ−スに抗血液凝固性を賦与する方法
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
JPS59160465A (ja) * 1983-03-04 1984-09-11 株式会社　バイオ・エンジニアリング・ラボラトリ−ズ 癒着阻止性医用材料およびその製造法
JPS59225064A (ja) * 1983-06-03 1984-12-18 ユニチカ株式会社 生理活性物質固定化用担体
JPS6014861A (ja) * 1983-07-05 1985-01-25 株式会社日本メデイカル・サプライ 癒着防止材
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US5002551A (en) * 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions

Also Published As

Publication number Publication date
MY100808A (en) 1991-02-28
US4840626A (en) 1989-06-20
NZ221806A (en) 1989-07-27
ES2047493T3 (es) 1994-03-01
AU7902687A (en) 1988-03-31
IE63282B1 (en) 1995-04-05
JP2563110B2 (ja) 1996-12-11
ATE98132T1 (de) 1993-12-15
JPS63102752A (ja) 1988-05-07
KR950013460B1 (ko) 1995-11-08
IE872604L (en) 1988-03-29
EP0262890A2 (en) 1988-04-06
EP0262890A3 (en) 1989-08-16
AU602726B2 (en) 1990-10-25
GR871484B (en) 1988-02-03
CA1300022C (en) 1992-05-05
DE3788404T2 (de) 1994-05-05
EP0262890B1 (en) 1993-12-08
ZA877284B (en) 1989-04-26
MX165863B (es) 1992-12-08
PH24128A (en) 1990-03-05
DK510687A (da) 1988-03-30
DK510687D0 (da) 1987-09-28
DE3788404D1 (de) 1994-01-20

Similar Documents

Publication Publication Date Title
KR880003605A (ko) 헤파린-함유 유착방지 장벽 및 사용방법
KR890700033A (ko) 외상치료 및 뼈 재생
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
KR960003732A (ko) 상처 치료용 멸균 겔 조성물
FI900052A0 (fi) Kompositioner och behandlingsmetoder foer hemorrojder och annat.
RS49918B (sr) Upotreba glp-1, ili analoga za lečenje infarkta miokarda
EA200000041A1 (ru) Способ лечения диабета тиазолидиндионом и метформином
KR870005637A (ko) 약물 데포
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ES2133289T3 (es) Aumento en los niveles de glutation con glutamina.
KR950016760A (ko) 치질 치료제
KR890700337A (ko) 신규한 연고와 그 연고를 이용하여 제조된 도포체 및 그들의 제조방법
DE68921002D1 (de) Verfahren und mittel zur präventiven behandlung von chirurgischen adhäsionen.
KR880003628A (ko) 처리된 리피드 조절제
SE7708176L (sv) Bensamidforeningar
KR920703060A (ko) 제약학적 배합물
Leonard et al. Adjunctive use of intravenous fluorescein in the tangential excision of burns of the hands
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
KR960003741A (ko) 조골세포 증식인자
KR900017599A (ko) 종양 치료용 약학 조성물
Lees et al. A comparison of the use of polythene sheet and Jelone® as temporary dressings for excised wounds
KR920702218A (ko) 피부 및 피하 조직에 대한 창상의 치료를 위한 라니티딘의 용도
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
KR890011595A (ko) 서맥 및 서부정맥 치료제
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20081024

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee